Sponsor Pipeline

Urotronic Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
3
Recruiting
Active Trials by Phase
Phase 4
1
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05383274 Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters Urethral Stricture Recruiting
Not specified
NCT07020520 EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric… Ureteral Stricture Recruiting
NCT06312722 Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study Benign Prostatic Hyperplasia Recruiting
NCT03499964 ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral… Urethral Stricture Active, Not Recruiting
NCT06560476 OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH Benign Prostatic Hyperplasia Active, Not Recruiting
NCT04131907 Optilume™ BPH Catheter System in Men With Symptomatic BPH Benign Prostatic Hyperplasia Active, Not Recruiting
Get alerts when Urotronic Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free